Pfizer

Page 36 of 37

Why America’s patent system is not killing innovation
Commentary

Why America’s patent system is not killing innovation

By
May 8, 2015
FRANCE-RESTAURANTS-BUSINESS-MCDONALDS
Features

McDonald’s hikes pay, and Europe targets Apple, Google — 5 things to know today

By
April 2, 2015
IL: Corporations In Illinois
Finance

Fat Pharma: Pfizer-Hospira and the top 10 overpriced drug deals ever

By
February 6, 2015
President Obama Remarks On Budget At Department Of Homeland Security
Commentary

U.S. corporate tax reform: why Obama’s good ideas don’t add up

By
February 5, 2015
American Pharmaceutical Company Pfizer Propose To Takeover British AstraZeneca
Finance

Pfizer to acquire Hospira in a deal worth about $15 billion

By
February 5, 2015
Earns Pfizer
Features

In speed mode, FDA approves Pfizer’s big new drug early

By
February 4, 2015
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Zoetis shares spike on reported Ackman stake purchase

By
November 11, 2014
Fortune
Features

Facebook earnings and MSG split — 5 things to know today

By
October 28, 2014
New Targets and new houses (oh, and Ebola) — 5 things to know today
Features

New Targets and new houses (oh, and Ebola) — 5 things to know today

By
October 24, 2014
Fortune
Finance

Are U.S. corporate tax inversions a necessary crisis?

By
July 18, 2014
Canada: A penalty box for pharma innovation
International

Canada: A penalty box for pharma innovation

By
July 2, 2014
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
Finance

AstraZeneca fails to win FDA panel backing for cancer treatment

By
June 26, 2014
AstraZeneca shareholders upset by “quick” Pfizer rejection
Finance

AstraZeneca shareholders upset by “quick” Pfizer rejection

By
May 20, 2014
Fortune
Finance

AstraZeneca rejects higher ‘final’ offer from Pfizer

By
May 19, 2014
Does the AstraZeneca-Pfizer deal make scientific sense?
Features

Does the AstraZeneca-Pfizer deal make scientific sense?

By
May 15, 2014

Most Popular